You may be interested in the following article which only showed an association between stroke and LVEF when LVEF was < 15%. I'm not 100% sure, but I don't think many participants in the DREAM-HF trial, if any, met this criteria. I expect Mesoblast would also be required to adjust their trial results for any confounding variables, including ejection fraction, when presenting their results to the FDA.
Title: Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure
https://www.ahajournals.org/doi/10.1161/STROKEAHA.116.013679
Silviu Itescu The Legend, page-302
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.008(0.54%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $3.033M | 2.175M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 78958 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 33977 | 33 |
View Market Depth
| Last trade - 14.23pm 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |